HNF1A and hepatocellular carcinoma: Our previous attempts to reintroduction of HNF1α using recombinant adenovirus has shown powerful treating effects of orthotopic liver tumors in mice [18], which establishes overexpression of HNF1α as a novel treatment strategy for HCC patients.